Business
Result of AGM
Renalytix plc announced that all resolutions were passed at its Annual General Meeting, with strong support for the adoption of the UK 2025 Annual Report (99.7% for) and the approval of the Directors' Remuneration Report (98.9% for). The re-appointment of directors received varying levels of support, with Christopher Mills at 90.3% and Erik Lium at 89.9% for, while other directors saw over 98% approval. The re-appointment of auditors PKF Littlejohn LLP was approved by 99.3% of votes, and the authorization to issue equity without pre-emptive rights passed with 97.9% in favour. Disclaimer*
About this update from Renalytix Plc
[{"type":"text","content":"\n\nRenalytix plc\n(\"Renalytix\" or the \"Company\")\n \nResult of AGM\n \nLONDON and NEW YORK, 9 December 2025 - Renalytix plc (LSE: RENX) (OTCQB: RNLXY), a precision medicine diagnostics company, with kidneyintelX.dkd, the only FDA-approved and Medicare reimbursed prognostic test to support early-stage risk assessment in chronic kidney disease, announces that at the Annual General Meeting (\"AGM\") held earlier today, all resolutions were duly passed.\n \nThe results of the AGM are detailed below:\n \n\n\n\n\n\n\n\nFor\n\n\n % voted in favour\n\n\n Against\n\n\n % voted against\n\n\n Withheld\n\n\n\n\nOrdinary resolutions\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1\n\n\nReceive and adopt the UK 2025 Annual Report\n\n\n196,930,280\n\n\n99.7\n\n\n587,105\n\n\n0.3\n\n\n20,878\n\n\n\n\n2\n\n\nApprove Directors' Remuneration Report\n\n\n195,421,372\n\n\n98.9\n\n\n2,073,488\n\n\n1.1\n\n\n43,403\n\n\n\n\n3\n\n\nRe-appointment of Christopher Mills as a Director\n\n\n178,267,303\n\n\n90.3\n\n\n19,130,050\n\n\n9.7\n\n\n140,910\n\n\n\n\n4\n\n\nRe-appointment of James McCullough as a Director\n\n\n194,129,345\n\n\n98.3\n\n\n3,268,008\n\n\n1.7\n\n\n140,910\n\n\n\n\n5\n\n\nRe-appointment of Fergus Fleming as a Director\n\n\n195,999,932\n\n\n99.3\n\n\n1,386,266\n\n\n0.7\n\n\n152,065\n\n\n\n\n6\n\n\nRe-appointment of Erik Lium as a Director\n\n\n177,457,676\n\n\n89.9\n\n\n19,928,522\n\n\n10.1\n\n\n152,065\n\n\n\n\n7\n\n\nRe-appointment of Julian Baines as a Director\n\n\n195,385,929\n\n\n99.3\n\n\n1,378,854\n\n\n0.7\n\n\n773,480\n\n\n\n\n8\n\n\nRe-appointment of Robert Naylor as a Director\n\n\n196,012,978\n\n\n99.3\n\n\n1,373,220\n\n\n0.7\n\n\n152,065\n\n\n\n\n9\n\n\nReappoint PKF Littlejohn LLP as Auditors\n\n\n196,188,779\n\n\n99.3\n\n\n1,276,304\n\n\n0.7\n\n\n73,180\n\n\n\n\n10\n\n\nAuthorise Board to determine auditors' remuneration\n\n\n196,927,685\n\n\n99.7\n\n\n555,598\n\n\n0.3\n\n\n54,980\n\n\n\n\n11\n\n\nAuthorise the Issue of Equity\n\n\n195,214,647\n\n\n98.9\n\n\n2,147,594\n\n\n1.1\n\n\n176,022\n\n\n\n\n \n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSpecial resolutions\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n12\n\n\nAuthorise Issue of Equity without Pre-emptive Rights\n\n\n193,317,050\n\n\n97.9\n\n\n4,042,090\n\n\n2.1\n\n\n179,123\n\n\n\n\n13\n\n\nAuthorise Market Purchase...